Cargando…
Editorial: Advances on targeted nanomedicines for atherosclerosis
The importance of nanomedicines for atherosclerosis. [Image: see text]
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615546/ https://www.ncbi.nlm.nih.gov/pubmed/36313335 http://dx.doi.org/10.3389/fphar.2022.1053938 |
| _version_ | 1784820444438724608 |
|---|---|
| author | Han, Qinggong He, Hongliang Zhang, Yu |
| author_facet | Han, Qinggong He, Hongliang Zhang, Yu |
| author_sort | Han, Qinggong |
| collection | PubMed |
| description | The importance of nanomedicines for atherosclerosis. [Image: see text] |
| format | Online Article Text |
| id | pubmed-9615546 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96155462022-10-29 Editorial: Advances on targeted nanomedicines for atherosclerosis Han, Qinggong He, Hongliang Zhang, Yu Front Pharmacol Pharmacology The importance of nanomedicines for atherosclerosis. [Image: see text] Frontiers Media S.A. 2022-10-14 /pmc/articles/PMC9615546/ /pubmed/36313335 http://dx.doi.org/10.3389/fphar.2022.1053938 Text en Copyright © 2022 Han, He and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Han, Qinggong He, Hongliang Zhang, Yu Editorial: Advances on targeted nanomedicines for atherosclerosis |
| title | Editorial: Advances on targeted nanomedicines for atherosclerosis |
| title_full | Editorial: Advances on targeted nanomedicines for atherosclerosis |
| title_fullStr | Editorial: Advances on targeted nanomedicines for atherosclerosis |
| title_full_unstemmed | Editorial: Advances on targeted nanomedicines for atherosclerosis |
| title_short | Editorial: Advances on targeted nanomedicines for atherosclerosis |
| title_sort | editorial: advances on targeted nanomedicines for atherosclerosis |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615546/ https://www.ncbi.nlm.nih.gov/pubmed/36313335 http://dx.doi.org/10.3389/fphar.2022.1053938 |
| work_keys_str_mv | AT hanqinggong editorialadvancesontargetednanomedicinesforatherosclerosis AT hehongliang editorialadvancesontargetednanomedicinesforatherosclerosis AT zhangyu editorialadvancesontargetednanomedicinesforatherosclerosis |